BeyondMD review

Two things make this worth a low-dose reader’s attention. The microdose is a named program with its own price rather than a smaller amount of a standard plan, and that price sits at the bottom of the field. More interesting is how it is described: not as a cheaper way to lose weight but as a precision-dosed protocol aimed at cardiometabolic and cellular effect. That is close to the actual case for microdosing, and much closer to it than the usual pitch, which treats a small dose as a discount and quietly implies the same results. Whether the specific effects claimed hold up is a separate question this site does not evidence, but the framing is at least pointed in the right direction. Keep the shelf it sits on in view. This is a broad peptide and longevity catalog — copper peptides, methylene blue, NAD+, sexual-health injectables — and the GLP-1 line is one part of it rather than the business itself. And every figure here, the microdose included, is a starting price with nothing published about what it starts from. No milligram appears anywhere, so the cheapest number tells you where the range opens and nothing about where your own dose lands in it.

Vs median

$44/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Prices the low dose on its own

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Varies by dose, plan or tier

Price last updated

August 2026

BeyondMD dispenses through a Not named facility. No bloodwork is required before you start. A clinician review is included in the price.

Two things make this worth a low-dose reader's attention. The microdose is a named program with its own price rather than a smaller amount of a standard plan, and that price is at the bottom of the field. More interesting is how it is framed: not as a cheaper way to lose weight but as a precision-dosed protocol aimed at cardiometabolic and cellular effect. That is close to the actual case for microdosing and much closer to it than the usual pitch, which treats a small dose as a discount. Whether the claimed effects hold up is a separate question the site does not evidence, but the framing is at least the right one. The context to keep in view is the shelf it sits on. This is a broad peptide and longevity catalog — copper peptides, methylene blue, NAD+, sexual-health injectables — and the GLP-1 line is one part of it rather than the business. And every figure on the site, the microdose included, is a starting price with nothing published about what it starts from. No milligram appears anywhere, so the cheapest number tells a reader where the range begins and nothing about where their own dose lands in it.

Every price is a starting figure with nothing published about what it starts from.

• No dose in milligrams appears behind any program, including the microdose.
• The GLP-1 line sits inside a broad peptide and longevity catalog rather than a metabolic clinic.

BeyondMD is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• Low dose vs full dose
• Titration planner
• The true annual cost of a plan